Literature DB >> 15378003

A new role for the Kruppel-like transcription factor KLF6 as an inhibitor of c-Jun proto-oncoprotein function.

Daniela A Slavin1, Nicolás P Koritschoner, Claudio C Prieto, Fernando J López-Díaz, Bruno Chatton, José Luis Bocco.   

Abstract

Kruppel-like transcription factors (KLFs) represent one of the most diverse set of regulators in vertebrate organisms. KLF family members are involved in cell proliferation and differentiation control in normal as well as in pathological situations. Here, we demonstrate that KLF6 behaves as a functional antagonist of the c-Jun proto-oncoprotein. Thus, KLF6 overexpression downregulated c-Jun-dependent transcription and a physical interaction between c-Jun and KLF6 was detected. Moreover, cell proliferation induced by c-Jun was significantly decreased by KLF6. The inhibition of c-Jun functions correlates directly with c-Jun protein degradation induced by KLF6. We also show that all KLF6 effects on c-Jun were largely dependent on phorbol ester (TPA/ionomycin) extracellular stimulation, which enhanced KLF6 nuclear translocation and transcriptional activity and modified its phosphorylation status. Our data are consistent with a novel mechanism of KLF6's role as an inhibitor of cell proliferation by counteracting the function of the c-Jun proto-oncoprotein involving enhanced c-Jun degradation by the proteasome-dependent pathway, and further reinforces KLF6 as a potential tumor suppressor gene product.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378003     DOI: 10.1038/sj.onc.1208020

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  36 in total

1.  Krüppel-like factor KLF9 regulates PPARγ transactivation at the middle stage of adipogenesis.

Authors:  H Pei; Y Yao; Y Yang; K Liao; J-R Wu
Journal:  Cell Death Differ       Date:  2010-08-20       Impact factor: 15.828

2.  Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas.

Authors:  Xiu-cheng Pan; Zhi Chen; Feng Chen; Xiao-hong Chen; Han-yin Jin; Xiao-yan Xu
Journal:  J Zhejiang Univ Sci B       Date:  2006-10       Impact factor: 3.066

3.  Enhanced hepatocarcinogenesis in mouse models and human hepatocellular carcinoma by coordinate KLF6 depletion and increased messenger RNA splicing.

Authors:  Diana Vetter; Michal Cohen-Naftaly; Augusto Villanueva; Youngmin A Lee; Peri Kocabayoglu; Rebekka Hannivoort; Goutham Narla; Josep M Llovet; Swan N Thung; Scott L Friedman
Journal:  Hepatology       Date:  2012-08-27       Impact factor: 17.425

4.  Carcinogen-induced hepatic tumors in KLF6+/- mice recapitulate aggressive human hepatocellular carcinoma associated with p53 pathway deregulation.

Authors:  Mirko Tarocchi; Rebekka Hannivoort; Yujin Hoshida; Ursula E Lee; Diana Vetter; Goutham Narla; Augusto Villanueva; Moshe Oren; Josep M Llovet; Scott L Friedman
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

5.  Decreased expression of KLF6 and its significance in gastric carcinoma.

Authors:  Qing Zhang; Xiao-ping Tan; Yue-sha Yuan; Cheng-ming Hu; Chang-hua He; Wei-zheng Wang; Jun-chuan Li; Qiu Zhao; Nan-zhi Liu
Journal:  Med Oncol       Date:  2009-12-05       Impact factor: 3.064

6.  Nuclear expression of KLF6 tumor suppressor factor is highly associated with overexpression of ERBB2 oncoprotein in ductal breast carcinomas.

Authors:  Ricardo C Gehrau; Diego S D'Astolfo; Catherine I Dumur; José L Bocco; Nicolás P Koritschoner
Journal:  PLoS One       Date:  2010-01-28       Impact factor: 3.240

7.  KLF6 inhibits estrogen receptor-mediated cell growth in breast cancer via a c-Src-mediated pathway.

Authors:  Jun Liu; Tian Du; Yufeng Yuan; YueMing He; Zui Tan; Zhisu Liu
Journal:  Mol Cell Biochem       Date:  2009-08-26       Impact factor: 3.396

8.  Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.

Authors:  Steven Yea; Goutham Narla; Xiao Zhao; Rakhi Garg; Sigal Tal-Kremer; Eldad Hod; Augusto Villanueva; Johnny Loke; Mirko Tarocchi; Kunihara Akita; Senji Shirasawa; Takehiko Sasazuki; John A Martignetti; Josep M Llovet; Scott L Friedman
Journal:  Gastroenterology       Date:  2008-02-13       Impact factor: 22.682

9.  KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis.

Authors:  Goutham Narla; Analisa DiFeo; Yolanda Fernandez; Saravana Dhanasekaran; Fei Huang; Jaya Sangodkar; Eldad Hod; Devin Leake; Scott L Friedman; Simon J Hall; Arul M Chinnaiyan; William L Gerald; Mark A Rubin; John A Martignetti
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

10.  Functional role of the KLF6 tumour suppressor gene in gastric cancer.

Authors:  Jaya Sangodkar; Jiayan Shi; Analisa DiFeo; Rachel Schwartz; Romina Bromberg; Aisha Choudhri; Kim McClinch; Raheleh Hatami; Elias Scheer; Sigal Kremer-Tal; John A Martignetti; Alex Hui; W K Leung; Scott L Friedman; Goutham Narla
Journal:  Eur J Cancer       Date:  2008-12-26       Impact factor: 9.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.